EMEA-002068-PIP01-16-M04
Key facts
Invented name |
Flucelvax Tetra
|
Active substance |
|
Therapeutic area |
Vaccines
|
Decision number |
P/0492/2021
|
PIP number |
EMEA-002068-PIP01-16-M04
|
Pharmaceutical form(s) |
Suspension for injection
|
Condition(s) / indication(s) |
Prevention of influenza
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
Seqirus Netherlands B.V.
E-mail: seqirus.clinicaltrials@seqirus.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|